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Abstract 
Post-market medical device surveillance is a challenge facing manufacturers, regulatory 
agencies, and health care providers. Electronic health records are valuable sources of real 
world evidence for assessing device safety and tracking device-related patient outcomes over 
time. However, distilling this evidence remains challenging, as information is fractured across 
clinical notes and structured records. Modern machine learning methods for machine reading 
promise to unlock increasingly complex information from text, but face barriers due to their 
reliance on large and expensive hand-labeled training sets. To address these challenges, we 
developed and validated state-of-the-art deep learning methods that identify patient outcomes 
from clinical notes without requiring hand-labeled training data. Using hip replacements —one 
of the most common implantable devices— as a test case, our methods accurately extracted 
implant details and reports of complications and pain from electronic health records with up to 
96.3% precision, 98.5% recall, and 97.4% F1, improved classification performance by 12.7- 
53.0% over rule-based methods, and detected over 6 times as many complication events 
compared to using structured data alone. Using these additional events to assess complication-
free survivorship of different implant systems, we found significant variation between implants, 
including for risk of revision surgery, which could not be detected using coded data alone. 
Patients with revision surgeries had more hip pain mentions in the post-hip replacement, pre-
revision period compared to patients with no evidence of revision surgery (mean hip pain 
mentions 4.97 vs. 3.23; t = 5.14; p < 0.001). Some implant models were associated with higher 
or lower rates of hip pain mentions. Our methods complement existing surveillance mechanisms 
by requiring orders of magnitude less hand-labeled training data, offering a scalable solution for 
national medical device surveillance using electronic health records.  
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Introduction 
For individuals implanted with the most widely used medical devices today, including 
pacemakers, joint replacements, breast implants, and more modern devices, such as insulin 
pumps and spinal cord stimulators, effective pre-market assessment and post-market 
surveillance are neccessary1 to assess their implants’ safety and efficacy. Device surveillance in 
the United States relies primarily on spontaneous reporting systems as a means to document 
adverse events reported by patients and providers, as well as mandatory reporting from 
manufacturers and physicians to the Food and Drug Administration (FDA). As a result, device-
related adverse events are significantly underreported — by some estimates as little as 0.5% of 
adverse event reports received by the FDA concern medical devices2. Recent adoption of 
universal device identifiers3,4 will make it easier to capture device details, and to report events 
using these identifiers, but linking devices to patient outcomes remains a challenge. Unique 
device identifiers have not been used historically (longitudinal data are essential to monitor 
device safety over time) and many relevant patient outcomes are simply not recorded in a 
structured form amenable for analysis. The International Consortium of Investigative Journalists 
recently analyzed practices of medical device regulation around the world and dissemination of 
device recalls to the public, sharing their findings in a report dubbed the ‘Implant Files’5. One 
issue highlighted in their report is the significant challenge of tracking device performance and 
reports of adverse events.  
Observational patient data captured in electronic health records (EHRs) are increasingly used 
as a source of real world evidence to guide clinical decision making, ascertain patient outcomes, 
and assess care efficacy6–8. Clinical notes in particular are a valuable source of real world 
evidence because they capture many complexities of patient encounters and outcomes that are 
underreported or absent in billing codes. Prior work has demonstrated the value of EHRs, and 
clinical notes specifically, in increasing the accuracy9 and lead time10 of signal detection for 
  
 
post-market drug safety surveillance. The hypothesis motivating this work is that EHRs, and 
evidence extracted from clinical notes in particular, can enable device surveillance and 
complement existing sources of evidence used to evaluate device performance. 
EHR structure and content varies across institutions, and technical challenges in using natural 
language processing to mine text data11 create significant barriers to their secondary use. 
Pattern and rule-based approaches are brittle and fail to capture many complex medical 
concepts. Deep learning methods for machine reading in clinical notes12–15 outperform these 
approaches to substantially increase event detection rates, but require large, hand-labeled 
training sets16,17. Thus recent research has led to new methods that use weak supervision, in 
the form of heuristics encoding domain insights, to generate large amounts of imperfectly 
labeled training data. These weakly supervised methods can exceed the performance of 
traditional supervised machine learning while eliminating the cost of obtaining large quantities of 
hand-labeled data for training18,19. Unlike labeled clinical data, these heuristics, implemented as 
programmatic labeling functions, can be easily modified and shared across institutions, thus 
overcoming a major barrier to learning from large quantities of healthcare data while protecting 
patient privacy.    
In this work, we demonstrate the use of such novel methods to identify real-world patient 
outcomes for the one of the most commonly implanted medical devices: the hip joint implant. 
More than one million joint replacements are performed every year in the United States and 
rates are increasing, including in patients under 65 years of age20. Primary joint replacements 
are expensive21, and implant failure incurs significant financial and personal cost for patients 
and the health care system. Recent recalls for metal-on-metal hip replacements22 highlight the 
need for scalable, automated methods for implant surveillance23.  While major adverse events 
such as deaths or revision surgery are typically reported, comprehensive device surveillance 
also needs to track outcomes that are reported less often, such as implant-related infection, 
loosening, and pain. Pain is a primary indication for undergoing a hip replacement, yet studies 
  
 
have found that more than 25% of individuals continue to experience chronic hip pain after 
replacement24,25. Pain is also an early indicator of the need for revision surgery26, and thus a key 
implant safety signal. 
Motivated by the potential impact and scale of this surveillance problem, we applied weak 
supervision and deep learning methods using the Snorkel framework19, to identify reports of 
implant-related complications and pain from clinical notes. After validating these machine 
reading methods, we combined data from clinical notes with structured EHR data to 
characterize hip implant performance in the real world, demonstrating the utility of using such 
text-derived evidence. We show that our methods substantially increase the number of identified 
reports of implant-related complications, that our findings complement previous post-approval 
studies, and that this approach could improve existing approaches to identify poorly performing 
implants.  
  
 
Methods 
We developed machine reading methods to analyze clinical notes and identify the implanted 
device used for a patient’s hip replacement, as well as identify mentions of implant-related 
complications and patient-reported pain. We evaluated these methods’ ability to (1) accurately 
identify implant-related events with a minimum of hand-labeled training data; and (2) map 
identified implants to unique identifiers -- a process called canonicalization -- to automatically 
replicate the contents of a manually curated joint implant registry.  
We then combined the data produced by our machine learning methods with structured data 
from EHRs to: (1) compare complication-free survivorship of implant models and (2) derive 
insights about associations between complications, pain, future revision surgery and choice of 
implant system.  
In the following sections, we first describe how we identified the patient cohort analyzed in our 
study. When then describe in detail our novel weakly supervised machine reading methods. 
Lastly, we describe our analysis of the performance of implant systems based on real world 
evidence produced by these methods, using Cox proportional hazards models, negative 
binomial models, and the t-test.  
Our study was approved by the Stanford University Institutional Review Board with waiver of 
informed consent, and carried out in accordance with HIPAA guidelines to protect patient data. 
Cohort construction 
We queried EHRs of roughly 1.7 million adult patients treated at Stanford Health Care between 
1995 and 2014 to identify patients who underwent primary hip replacement and/or revision 
surgery. To find records of primary hip replacement surgery, we used ICD9 procedure code 
81.51 (total hip replacement) and CPT codes 27130 (total hip arthroplasty) and 27132 
  
 
(conversion of previous hip surgery to total hip arthroplasty). To find structured records of hip 
replacement revision surgery, we used ICD9 procedure codes 81.53 (Revision of hip 
replacement, not otherwise specified), 00.70, 00.71, 00.72 and 00.73 (Revision of hip 
replacement, components specified), and CPT codes 27134 (Revision of total hip arthroplasty; 
both components, with or without autograft or allograft), 27137 (Revision of total hip 
arthroplasty; acetabular component only, with or without autograft or allograft) and 27138 
(Revision of total hip arthroplasty; femoral component only, with or without allograft). 
We identified 6,583 patients with records of hip replacement surgery, of which, 386 (5.8%) had 
a coded record of at least one revision after the primary surgery. For all patients in the resulting 
cohort, we retrieved the entirety of their structured record (procedure and diagnosis codes, 
medication records, vitals etc.), their hip replacement operative reports, and all clinical notes. 
We were able to retrieve operative reports for 5,801 (88%) hip replacement patients. 
Machine Reading 
Background on weak supervision 
In supervised machine learning, experts employ a wide range of domain knowledge to label 
ground truth data. Data programming18,19 is a method of capturing this labelling process using a 
collection of imperfect heuristics or labeling functions which are used to build large training sets. 
Labeling functions encode domain expertise and other sources of indirect information or weak 
supervision (e.g., knowledge bases, ontologies) to vote on a data item’s possible label. These 
functions may overlap, conflict, and have unknown accuracies. Data programming unifies these 
noisy label sources, using a generative model to estimate and correct for the unobserved 
accuracy of each labeling source and assign a single probabilistic label to each unlabeled input 
sample. This step is unsupervised and requires no ground truth data. The generative model is 
  
 
used to programmatically label a large training set, to learn a discriminative model such as a 
neural network. By training a deep learning model, we transform rules into learned feature 
representations, which allows us to generalize beyond the original labeling heuristics, resulting 
in improved classification performance.  
The probabilistic labels generated via data programming results in a large training set which is 
referred to as “weakly labeled”. The discriminative model gets as input the original text 
sentences in the training set and the probabilistic labels generated by the data programming 
step. Because the label provided in such a supervised learning setup is “weak”, the process is 
also called “weak supervision” and the resulting discriminative model referred to as a weakly 
supervised model. We describe each step of the process (Figure 1) in the following sections. 
 
Figure 1. Overview of our machine reading pipeline. Top: Each patient’s EHR is processed to 
extract the date of primary hip replacement surgery, any coded record of revision surgeries, and 
all clinical and operative notes. Bottom: From the patient’s coded data and primary hip 
replacement operative report, we tagged all mentions of implants, complications, and 
anatomical locations. We defined pairs of relation candidates from these sets of entities, and 
labeled them using data programming via the Snorkel framework. These labeled data were then 
used to train a deep learning model. When applied to unseen data, the final model’s final output 
  
 
consists of timestamped, structured attribute data for implant systems, implant-related 
complications, and mentions of pain.  
Implant type, implant-related complications, and pain event definitions 
We defined 3 entity/event types : (1) implant manufacturer/model entities, e.g., “Zimmer 
VerSys”; (2) implant-related complications, e.g., “infected left hip prosthetic”; and (3) patient-
reported pain at a specific anatomical location, e.g., “left hip tenderness”.  The latter two, 
implant complications and patient-reported pain, involve multiple concepts and were formulated 
as relational inference tasks27 where a classifier predicts links between two or more entities or 
concepts found anywhere in a sentence, i.e., R = r(ci...cN), where r is a relation type and 
ci is a concept mention. This formulation allowed our classifier  learn complex semantic 
relationships between sentence entities, using statistical inference to capture a wide range of 
meaning in clinical notes. This approach enabled identifying nuanced, granular information, 
such as linking pain and complication events to specific anatomical locations and implant 
subcomponents (e.g, “left acetabular cup demonstrates extreme liner wear”). Therefore, 
complication outcomes were represented as entity pairs of(complication, implant)and 
pain outcomes as pairs of (pain, anatomy). 
We considered all present positive mentions of an event —i.e., the event was contemporaneous 
with a note’s creation timestamp— as positive examples. Historical, negated and hypothetical 
mentions were labeled as ‘negative’. Implant complications were further broken down into 6 
disjoint subcategories: revision, component wear, mechanical failure, particle disease, 
radiographic abnormality, and infection (see supplement for examples). These categories 
correspond to the removal of specific hardware components as well as common indicators of 
device failure. 
  
 
Text Preprocessing 
All clinical notes were split into sentences and tokenized using the spaCy28 framework. Implant, 
complication, anatomy, and pain entities were identified using a rule-based tagger built using a 
combination of biomedical lexical resources, e.g., the Unified Medical Language System 
(UMLS) 29 and manually curated dictionaries (see supplement for details). Each sentence was 
augmented with markup to capture document-level information such as note section headers 
(e.g., “Patient History”) and all unambiguous date mentions (e.g., “1/1/2000”) were normalized 
to relative time delta bins (e.g., “0-1 days”, “+5 years”) based on document creation time. Such 
markup provides document-level information to incorporate into features learned by the final 
classification model.  
Candidate relations were defined as the Cartesian product of all entity pairs defining a relation 
(i.e., pain/anatomy and implant/complication) for all entities found within a sentence. Candidate 
events and relations were generated for all sentences in all clinical notes.  
Labeling Functions  
Labeling functions leverage existing natural language tools to make use of semantic 
abstractions or primitives which make it easier for domain experts to express labeling heuristics. 
For example, primitives include typed named entities such as bacterium or procedures, 
document section structure, as well as negation, hypothetical, and historical entity modifiers 
provided by well-established clinical natural language processing methods such as 
NegEx/ConText30,31. These primitives provide a generalized mechanism for defining labeling 
functions that express intuitive domain knowledge, e.g., “Implant complications found in the 
‘Past Medical History’ section of a note are not present positive events” (Figure 2). Primitives 
can be imperfect and do not need to be directly provided to the final discriminative model as 
features. Critically, the end deep learning discriminative model automatically learns to encode 
  
 
primitive information using only the original text and the training signal provided by our imperfect 
labels.  
We developed labeling functions to identify implant-related complications and pain and its 
anatomical location. In total, 50 labeling functions were written, 17 shared across both tasks, 
with 7 task-specific functions for pain-anatomy and 25 for implant-complications. Labeling 
functions were written by inspecting unlabeled sentences and developing heuristics to assign 
individual labels (supplemental figure S2). This process was iterative, using development set 
data (described in the next section) to refine labeling function design.  
 
Figure 2. Labeling function examples. Clinical notes (top left) are preprocessed to generate 
document markup, tagging entities with parent section headers and historical, hypothetical, 
negated attributes.  Labeling functions (top right) use this markup to represent domain insights 
as simple Python functions, e.g., a function to label mentions found in “Past Medical History” as 
FALSE because they are likely to be historical mentions rather than a current condition. These 
labeling functions vote {FALSE, ABSTAIN, TRUE} on candidate relationships (bottom) to 
generate a vector of noisy votes for each candidate relationship. The data programming step 
  
 
described in Figure 1 uses this labeling function voting matrix to learn a generative model which 
assigns a single probabilistic label to each unlabeled candidate relationship. 
Manually annotated datasets 
We used two sources of manually annotated data to evaluate our methods: (1) the Stanford 
Total Joint Registry (STJR), a curated database of joint replacement patients maintained by 
Stanford Health Care orthopedic surgeons which, as of March 2017, contained records for 
3,714 patients and (2) clinical notes from the Stanford Health Care EHR system, manually 
annotated by co-authors and medical doctors expressly for the purpose of evaluating our 
models’ performance. The clinical notes manually annotated by our team consisted of three 
sets:  
A. 500 operative reports annotated to identify all implant mentions. 
B. 802 clinical notes annotated to identify all complication-implant mentions.  
C. 500 clinical notes annotated to identify all pain-anatomy relation mentions.  
Set A was randomly sampled from the entire hip replacement cohort’s operative report corpus, 
using the manufacturer search query “Zimmer OR Depuy”. This query captured >85% of all 
implant components in the STJR and accounted for >90% of all implant mentions in operative 
reports. Sets B and C were randomly sampled with uniform probability from the entire hip 
replacement cohort’s clinical note corpus. Ground truth labels for implant model mentions (set 
A) were generated by one annotator (author AC). Ground truth labels for complication-implant 
mentions (set B) were generated by 5 annotators (authors AC, JF, and NHS, and two medical 
doctors). Ground truth labels for set C were generated by 3 annotators (authors AC and JF, and 
one medical doctor). We used adjudication to resolve differences between annotators. 
  
 
Classification Models 
For implant manufacturer/model entity extraction (e.g., “DePuy Pinnacle”, “Zimmer Longevity”), 
we used a rule-based tagger, as we found using dictionary-based string matching was 
sufficiently unambiguous to achieve high precision and recall (see supplemental methods for 
detail on the construction of the implant dictionary used). 
We used a Bidirectional Long Short-Term Memory (LSTM) 32 neural network with attention33 as 
the discriminative model for relational inference tasks. All LSTMs used word embeddings pre-
trained using FastText34 on 8.1B tokens (651M sentences) of clinical text. Each training instance 
consisted of an entity pair, its source sentence, and all corresponding text markup. All models 
were implemented using the Snorkel framework. 
Evaluation 
We evaluated our implant extraction system using the 500 manually annotated operative reports 
(set A, above). We evaluated our weakly supervised pain and complication LSTMs against two 
baselines: (1) a traditionally supervised LSTM trained using 150 hand-labeled training 
documents; (2) the soft majority vote of all labeling functions for a target task. To quantify the 
effect of increasing training set size, we evaluated the weakly supervised LSTM neural networks 
trained using 150 to 50,000 weakly-labeled documents. We used training, development, and 
test set splits of 150/19/633 from set B for implant-complication relations and 150/250/100 
documents from set C for pain-anatomy relations. All models and labeling functions were tuned 
on the development split and results reported are for the test split. All models were scored using 
precision, recall, and F1-score. 
We then compared the structured output of our implant extraction method to the STJR. Given a 
patient, an implant component, and a timestamped hip replacement surgery, agreement was 
defined as identical entries for the component in both the STJR and our system’s output; conflict 
  
 
was where the implant component(s) were recorded for a hip replacement surgery in both STJR 
and our data but did not match; missingness is where a record for a hip replacement surgery 
was absent in either STJR or our data. We canonicalized all implant models to the level of 
manufacturer/model, i.e., the same resolution used by the STJR. 
Characterizing hip implant performance in the real world 
We analyzed complication-free survival of implant systems using Cox proportional hazards 
models, controlling for age at the time of hip replacement, gender, race, ethnicity and Charlson 
Comorbidity Index (CCI). CCI was categorized as none (CCI = 0), low (CCI = 1), moderate (CCI 
= 2) or high (CCI ≥ 3). For patients with multiple complications, we calculated survival time from 
primary hip replacement to first complication. We performed this analysis for a composite 
outcome of ‘any complication’, and also for each class of complication extracted by our text 
processing system. 
To quantify association between implant systems and hip pain, we fit a negative binomial model 
to the frequency of hip pain mentions in the year post-hip replacement. The model included the 
following covariates: implant system, age at the time of hip replacement,gender, race, ethnicity, 
frequency of hip pain mentions in the year prior to surgery (to account for baseline levels of hip 
pain), and follow-up time post-THA (to a maximum of one year). For the subset of patients with 
body mass index (BMI) data available, we also fit models that included BMI as a covariate. 
We specified implant system as an interaction term between femoral and acetabular 
components, grouping infrequently occurring interactions into a category "other". The frequency 
cutoff for inclusion in the "other" category was chosen in a data-driven manner using Akaike 
information criterion (AIC) to find the cutoff resulting in best model fit. We specified the most 
frequent system (Zimmer Trilogy acetabular + VerSys femoral component) as the reference 
interaction term. 
  
 
To assess the association between revision and hip pain, we tested the hypothesis that hip-
specific pain mentions were more frequent in patients with a coded record of revision compared 
to those who without. We used the two-sided t-test, controlling for post-implant follow-up time. 
 
For all implant system analyses, we restricted the analysis to the 2,704 patients with a single hip 
replacement, a single femoral component and a single acetabular component. 
All statistical analyses were performed using R 3.4.0. 
Code availability 
Code, dictionaries, and labeling function resources required to extract implant details, 
complication-implant and pain-anatomy relations are publicly available at 
https://github.com/som-shahlab/ehr-rwe. Included are Jupyter Notebooks that run the 
complication-implant and pain-anatomy inference code end-to-end on MIMIC-III35 notes. 
  
  
 
Results 
We first describe the cohort analyzed in our study and report the performance of our implant 
extraction method and weakly supervised relation extraction methods in comparison to 
traditionally supervised models. We then compare the ability of our method to replicate the 
contents of the manually curated STJR joint implant registry. Lastly, we present our findings 
when combining the evidence produced by our extraction methods with structured data from 
EHRs to characterize hip implant performance in the real world, demonstrating the utility of such 
text processing methods. 
Cohort summary 
We identified 6,583 patients with records of hip replacement surgery. The hip replacement 
cohort was 55.6% female, with an average age at surgery of 63 years and average follow-up 
time after replacement of 5.3 years (± 2.1 years). Of these 6,583 patients, 386 (5.8%) had a 
coded record of at least one revision surgery. For patients who had a revision surgery, the 
average age at primary replacement surgery was 57.9 years and average follow-up time was 
10.5 years (± 3.0 years).  
Performance of machine reading methods  
The performance of our implant, complication, and pain extraction methods based on test sets 
of manually annotated records is summarized in Table 1. 
 
 
 
 
  
 
Table 1. Precision, recall and F1 of our best performing entity and relation extraction methods. 
Category Task Type Precision Recall F1 Test set size 
Implant Manufacturer/Model  Entity 96.3 98.5 97.4 500 
Pain-Anatomy Relation 80.2 82.6 81.4 100 
Implant-Complication  Relation 82.7 62.3 71.1 633 
Comparison of weakly supervised models to baseline models 
Table 2 reports the performance of our relation extraction models compared against the 
baselines described in the methods. Using weakly-labeled training data substantially improved 
performance in all settings. Weakly supervised LSTM models improved 9.2 and 24.7 F1 points 
over the soft majority vote baseline, with 17.8 and 29.9 point gains in recall. Directly training an 
LSTM model with just the 150 hand-labeled documents in the training set increased recall 
(+13.6 and +15.4 points) over the majority vote for both tasks, but lost -8.9 and -30.9 points in 
precision. These results show that training using large amount of generated, imperfectly labeled 
data is beneficial in terms of recall, while preserving precision.  
For subcategories of implant complications, F1 was improved by 16.2 to 496% for different 
categories except radiographic abnormalities, where a rule-based approach performed 18.5% 
better. In general, models trained on imperfectly labeled data provided substantial increases in 
recall, especially in cases such as particle disease, where rules alone had very low recall.   
 
 
 
  
 
Table 2. Performance of weakly supervised relation extraction compared with baselines. Blue 
highlights show highest value for a given metric. Gray rows are subcategories of implant 
complications. 
 
Complication Types 
Menti
ons 
BASELINE 
Soft Majority Vote 
150 Hand-labeled 
documents in the  
training set  
Weakly 
Supervised Model 
+/- F1 
Count P R F1 P R F1 P R F1 % 
Pain-Anatomy 236 81.4 64.8 72.2 72.5 78.4 75.4 80.2 82.6 81.4 +12.7 
Implant-Complication 276 81.7 32.4 46.4 50.8 47.8 49.3 82.7 62.3 71.1 +53.2 
Revision   63 74.4  46.0  56.9 41.7  68.3  51.8 75.5  58.7  66.1 +16.2 
Component Wear  48 71.4  41.7 52.6 78.9  31.9  45.5 72.9  72.9  72.9 +38.6 
Mechanical Failure 25 87.5 28.0 42.4 21.9  28.0  24.6 91.7 44.0 59.5 +40.3 
Particle Disease   65 80.0 6.2 11.4 53.8 32.3  40.4 97.1 52.3 68.0 +496.5 
Radiographic 
Abnormality 
17 100.0 37.5 54.5 37.0 55.6 44.4 60.0 35.3 44.4 -18.5 
Infection  58 100.0  39.7 56.8 90.0 62.1 73.5 90.7 84.5 87.5 +54.0 
 
Figure 3 shows the impact of training set size on the weakly supervised LSTM’s performance for 
identifying implant complications.  With training set sizes greater than 10,000 weakly labeled 
documents, LSTM models outperformed rules across all possible classification thresholds, with 
a 51.3% improvement in area under the precision-recall curve (PR-AUC) over soft majority vote.  
 
  
 
 
Figure 3. Precision Recall (PR) curves for Implant-Complication classifier performance at 
different training set sizes. The soft majority vote (SMV) baseline consists of a majority vote of 
all labeling functions applied to test data. Note how SMV favors precision at substantial cost to 
recall. A classifier trained directly on the 150 hand-labeled training documents failed to produce 
a high-performance model. When training using the generated imperfectly labeled training data, 
at 10k - 20k documents, the resulting supervised LSTMs are better than SMV at all threshold 
choices. The model trained on 20k documents performed best overall, with a 51.3% 
improvement over SMV in average precision (PR-AUC).  
Comparison with total joint registry 
The STJR snapshot covered 3,714 patients. 2,850 STJR patients underwent surgery during the 
time period of this study (1995-2014). 1,877 STJR patients overlapped with our hip replacement 
cohort (Figure 4) and were used to evaluate model performance. 
 
  
 
 
Figure 4. Overlap between Stanford Total Joint Registry (STJR) and the hip replacement cohort 
extracted from the Stanford Medicine Research Data Repository (STaRR). Of the 6,583 patients 
in the hip replacement cohort, 782 patients did not have an operative report (white box with 
dotted outline). For the 5,801 patients with operative reports, 807 did not have a mention of any 
implant model in their report(s) (striped box). Of the remaining 4,994 patients (light gray box), 
1,877 overlapped with the STJR. Of the 477 patients whose 500 operative reports were 
manually annotated (dark gray box), 185 overlapped with the STJR. 973 patient records were 
present only in the STJR (white box with dashed outline). 
For the most frequently implanted systems with ≥1 records present in the STJR (Zimmer Biomet 
Trilogy, DePuy Pinnacle, Depuy Duraloc, Zimmer Biomet Continuum, Zimmer Biomet RingLoc, 
Zimmer Biomet VerSys, Depuy AML and Zimmer Biomet M/L Taper; which corresponded to 
88% of patients in the STJR/cohort overlapping set), there was 72% agreement between STJR 
and our system output, 17% conflict and 11% missingness. 
  
 
Hip implant system performance in the real world 
In the following sections we summarize our analysis of hip implant performance using the 
evidence identified by our machine reading methods. First we quantify additional evidence of 
revision identified by our methods, and the association between implant system and risk of 
revision. Next, we summarize our analysis of the association between implant systems and 
post-implant complications generally. Lastly, we describe our findings regarding the association 
between implant system, hip pain, and revision. Our first two analyses used Cox proportional 
hazards models to measure the association between implant system and revision/post-implant 
complications. Our thirds analysis used a negative binomial model to investigate the association 
between implant system and frequency of hip pain mentions over time, and a t-test to 
investigate the association between hip pain and revision surgery. 
Unstructured data captures additional evidence of revision 
In the analyzed subset of 2,704 patients with a single implant, only 78 had a coded record of 
revision surgery (as an ICD or CPT code in a billing record, for example). Considering only this 
evidence of revision, there was no significant association between implant system and revision-
free survival (log-rank test p = 0.8; see supplementary Figure S2). When including evidence of 
revision extracted from clinical notes, we detected an additional 504 revision events (over 6 
times as many events). In total, our methods identified 519 unique revision events (63 revision 
events that were detected in both coded data and text for a single patient were merged, and 
assigned the timestamp of whichever record occurred first). 63/78 (81%) of the coded revision 
events have corresponding evidence of the revision extracted from clinical notes by our system. 
The majority of coded records and text-derived revision events occur within 2 months of each 
other, suggesting good agreement between these two complementary sources of evidence 
when both do exist.  
  
 
 
Analyzing the augmented revision data using a Cox proportional hazards model, different 
implant systems are associated with a significantly higher or lower risk of revision when 
controlling for age at the time of implant, race, gender, and Charlson Comorbidity Index (log-
rank test p < 0.001). Figure 5 summarizes the risk of revision for implant systems when 
including evidence from clinical notes alongside structured records of revision. 
 
Figure 5. Summary of Cox proportional hazards analysis of the risk of revision for each 
hip implant system. The table on the left lists the number of patients implanted with each 
system, the number of revision events observed for each, and the total person-years of data 
available. The forest plot displays the corresponding hazard ratio, with the hazard ratio (95% 
  
 
confidence interval) and p-value listed in the table to the right. Note that this figure only shows 
implant systems for which at least one revision event was detected. 
Post replacement complications are associated with implant systems 
In addition to revision, the Cox proportional hazards analysis of post-hip replacement 
complications indicates that some implant systems are associated with a higher or lower risk of 
implant-related complications overall (log-rank test p < 0.001) and of specific types (see 
supplementary results, Figures S3-S7, for specific complication types). For example, the Depuy 
Pinnacle (acetabular component) + AML (femoral component) system has a significantly lower 
risk of overall complications in comparison to the Zimmer Biomet Trilogy (acetabular) + VerSys 
(femoral) system, when controlling for age at the time of implant, race, gender, and Charlson 
Comorbidity Index (see Figure 6). 
 
  
 
 
Figure 6. Summary of Cox proportional hazards analysis of the risk of any complication 
for each hip implant system. The table on the left lists the number of patients implanted with 
each system, the number of complication events observed for each, and the total person-years 
of data available. The forest plot displays the corresponding hazard ratio, with the hazard ratio 
(95% confidence interval) and p-value listed in the table to the right. Note that this figure only 
shows implant systems for which one complication event was observed. 
Post replacement hip pain is associated implant systems and revision 
Our system extracted 938,222 positive pain-anatomy relation mentions from 471,985 clinical 
notes for 5,562 hip replacement patients, with a mean of 168 mentions per patient, and 1 
mention per note. Fitting a negative binomial model to the subset of this data corresponding to 
  
 
the 2,704 patients with a single implant, we found that some implant systems are associated 
with frequency of hip pain mentions in the year following hip replacement surgery. Other 
covariates that also associated with frequency of post-implant hip pain are hip pain in the year 
prior to hip replacement, having the race category “other”, unknown ethnicity, and follow-up time 
(see supplementary Table S1 for all model coefficients). 
Table 3 lists implant systems with statistically significant negative binomial model coefficients (p 
≤ 0.05), their incidence rate ratios (IRR) and 95% confidence intervals. Six systems, all 
manufactured by Depuy, had IRRs <1, indicating that they are associated with lower rates of hip 
pain mentions relative to the Zimmer Biomet Trilogy + VerSys reference system when 
controlling for patient demographics, pain mentions in the prior year and CCI. Five systems (4 
Zimmer Biomet, 1 Depuy) have IRRs > 1, indicating that they are associated with higher rates of 
hip pain mentions following implant. 
For 1,463 patients who had a BMI measurement within 100 days of hip replacement, we 
assessed whether hip pain mentions in the year following implant varies with BMI by including it 
in a negative binomial model alongside the above variables. We found no statistically significant 
association between BMI and pain in the year following hip replacement (p = 0.29). 
 
 
 
 
 
 
 
 
  
 
Table 3. Negative binomial model-derived incidence rate ratios (IRRs), 95% confidence 
intervals (CI) and associated p-values for implant systems significantly associated with 
frequency of hip pain mentions in the year following hip replacement. 
Implant System IRR (95% CI) p-value 
Depuy Duraloc + AML 0.033 (0.012 - 0.091) < 0.001 
Depuy Duraloc + Corail 1.268 (1.020 - 1.577) 0.033 
Depuy Duraloc + Summit 0.161 (0.040 - 0.652) 0.011 
Depuy Pinnacle + AML 0.097 (0.057 - 0.163) < 0.001 
Depuy Pinnacle + Corail 0.594 (0.475 - 0.742) < 0.001 
Depuy Pinnacle + Endurance 0.032 (0.010 - 0.137) < 0.001 
Depuy Pinnacle + Summit 0.369 (0.301 - 0.432) < 0.001 
Zimmer Biomet Continuum + M/L Taper 2.061 (1.561 - 2.720) < 0.001 
Zimmer Biomet Ranawat/Burstein + Taperloc 2.061 (1.174 - 3.621) 0.012 
Zimmer Biomet Trilogy + M/L Taper 1.490 (1.234 - 1.799)  < 0.001 
 
Mean post-hip replacement hip pain mention frequency is significantly higher in patients who 
underwent revision surgery, when controlling for length of post-implant follow-up time (8.94 vs. 
3.23; t = 17.60; p < 0.001). This holds true when considering only the period between primary 
hip replacement and revision for those patients who had revision surgery (4.97 vs. 3.23; t = 
5.14; p < 0.001). 
  
 
Discussion 
Post-market medical device surveillance in the United States currently relies on spontaneous 
reporting systems such as the FDA’s Manufacturer and User Facility Device Experience 
(MAUDE), and increasingly on device registries36–39. Neither source provides a complete or 
accurate profile of the performance of medical devices in the real world23.  Submitting data to 
registries is voluntary and not all records capture complete details on primary procedure, 
surgical factors, complications, comorbidities, patient reported outcomes, and radiograph40, so 
existing state and health system-level registries are not comprehensive. The shortcomings of 
spontaneous reporting systems, which are well known in pharmacovigilance research41,42 
(including lack of timeliness, bias in reporting, and low reporting rates), also plague device 
surveillance efforts43. EHRs, with their continuous capture of data from diverse patient 
populations and over long periods of time, offer a valuable source of evidence for medical 
device surveillance in the real world, and complement these existing resources. Indeed, the 
FDA’s new five year strategy44 for its Sentinel post-market surveillance system prioritizes 
increased capture of data from EHRs. Our methods to extract evidence for device safety signal 
detection from EHRs directly support these efforts. 
Our inference-based methods for identifying the implant manufacturer/model, pain and 
complications from the EHR were very accurate (F1 97.4; 81.4; 71.1) and substantially 
outperformed pattern and rule-based methods. Moreover, these machine learning methods can 
be deployed continuously, enabling near real-time automated surveillance. Comparing our 
method’s output to a manually curated joint registry, we achieved majority agreement with 
existing registry records and increased coverage of hip replacement patients by 200%. 
Discrepancies between implant information extracted from operative reports and the 
corresponding registry record primarily resulted from variability in how implant system names 
were recorded; thus, one way our methods can augment existing registries is to standardize 
  
 
record capture. Our findings highlight the importance of using evidence derived from clinical 
notes in evaluating device performance. Our methods identified significantly more evidence of 
revision surgery (over 6X more events than from codes alone), augmenting what is available in 
structured EHR data. Our finding that text-derived evidence increases the observed rate of 
complications in comparison to coded data agrees with studies of the completeness and 
accuracy of ICD coding for a variety of diseases45, and for comorbidities and complications of 
total hip arthroplasty specifically46,47.  
 
We found that a subset of implant systems were associated with higher or lower risk of implant-
related complications in general, and of specific classes of complication. A recent meta-analysis 
of implant combinations48 found no association between implant system and risk of revision, 
although other studies have mixed conclusions49–54. These studies relied on structured records 
of revision and registry data, and thus are complemented by our analysis of real world evidence 
derived from EHRs. We also found that patients with structured records of revision surgery 
reported more hip pain in the post replacement, pre-revision period than patients who did not. 
This agrees with previous findings36,55 that pain is an early warning sign of complications that 
result in revision surgery.  
Our approach leverages data programming to generate training sets large enough to take 
advantage of deep learning32 for relational inference (which is one of the most challenging 
problems in natural language processing27). The resulting models sacrificed small amounts of 
precision over a rule-based approach for significant gains in recall, demonstrating their ability to 
capture complex semantics and generalize beyond input heuristics. This approach requires only 
a small collection of hand-labeled data to validate end model performance. By focusing on 
creating labeling functions, instead of manually labeling training data, we achieved state-of-the-
art performance using code that, unlike labeled data, can be easily updated and shared across 
different healthcare systems. 
  
 
There are several limitations to our work. We were not able to retrieve operative reports for all 
hip replacement patients and thus likely missed some implants. Patients had different numbers 
of clinical notes, at varying time points, which may not have captured their full experience of 
pain or complications following surgery. Our approach canonicalized implants to the level of 
manufacturer/model names, which only identifies broad implant families rather than the specific 
details provided by serial and lot numbers. However, as the use of unique device identifiers 
grows in popularity, our approach can incorporate this information to further differentiate the 
performance of implants with different design features. Our study was necessarily restricted to 
the implant systems used by Stanford Health Care surgeons, and thus our findings are limited to 
those systems. While we controlled for patient age, gender, race, ethnicity, hip pain mentions 
prior to surgery, and CCI in our statistical analyses, there are additional patient- and practice-
specific features that may confound the complication-free survival of individual implants and 
rates of post-implant hip pain. These include case complexity, the orthopaedic surgeon who 
performed the hip replacement, their preference for specific implant systems, and their case 
mix. CCI is an indicator of case complexity, but joint arthroplasty-specific factors, such as 
indication for surgery, also contribute to patients’ overall complexity. Lastly, our analysis was 
restricted to patients who underwent a single hip replacement, to avoid attributing a 
complication or pain event to the incorrect implant, in the case of patients who underwent 
multiple primary implant procedures. 
In conclusion, we demonstrate the feasibility of a scalable, accurate, and efficient approach for 
medical device surveillance using EHRs. We have shown that implant manufacturer and model, 
implant-related complications, as well as mentions of post-implant pain can be reliably identified 
from clinical notes in the EHR. Leveraging recent advances in machine reading and deep 
learning, our methods require orders of magnitude less labeled training data and obtain state-of-
the-art performance. Our findings that implant systems vary in their revision-free survival and 
that patients who had revision surgery had more mentions of hip pain after their primary hip 
  
 
replacement agree with multiple prior studies. Associations between implant systems, 
complications, and hip pain mentions as found in our single-site study only demonstrate the 
feasibility of using EHRs for device surveillance, but do not establish causality. The ability to 
quantify pain and complication rates automatically over a large patient population offers an 
advantage over surveillance systems that rely on individual reports from patients or surgeons. 
We believe that the algorithms described here can be readily scaled, and we make them freely 
available for use in analyzing electronic health records nationally.  
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Supplemental Material 
Supplemental Methods 
Dictionary-based preprocessing 
For hip implant systems, we built a dictionary of system names by querying the FDA Global 
Unique Device Identifier Database 56, which captures >900 hip implant components including 
femoral stems, femoral heads, acetabular components, and liners. For pain, we built a 
dictionary of 31 terms (e.g. ‘pain’, ‘tender’,) through manual inspection of notes. A complications 
dictionary of 452 terms was built via manual inspection of notes by clinical experts. Dictionaries 
were automatically expanded using an open source corpus processor 57 to capture synonyms 
and misspellings. The dictionary of anatomical entities consisted of all strings in the 
Foundational Model of Anatomy (FMA) 58, a small dictionary of informal abbreviations (“abd” -> 
“abdomen”), and regular expressions for standard anatomical terms of position (e.g., “lateral left 
knee”). 
 
 
  
 
 
Figure S1. The labeling function development and model evaluation workflow. In (1) domain 
experts examine unlabeled candidate relationships to gain insight into writing and refining 
labeling functions. These functions are then empirically evaluated for accuracy, precision, recall, 
and F1 score on an expert-labeled development set. This is an iterative process until the 
desired labeling function performance is achieved on the development set. In (2) the final 
labeling functions are applied to a large collection of unlabeled data to generate probabilistic 
labels for training a deep learning model. The resulting trained model is evaluated on expert-
labeled unseen test set. This approach requires orders of magnitude less hand-labeled data 
than what would be needed for directly training deep learning model in (2), because hand-
labeled data is only used to develop labeling functions and to evaluate final model performance. 
Concept extraction models 
By restricting our implant candidate extraction to the specific operative notes for each patient’s 
THA procedure, we sufficiently disambiguated implant mentions to achieve high performance 
  
 
using dictionary-based string matching. Thus our implant candidates were used directly as our 
final implant outputs.  
For pain extraction, we learned a generative model from labeling functions applied to unlabeled 
patient notes to create a probabilistically labeled training set. We then used this data to train a 
state-of-the-art Bidirectional Long Short-Term Memory (LSTM) 32 neural network with attention 
as our end discriminative model. Hyperparameter tuning was done using random search over 
10 models, using a parameter grid derived from the literature (batch_size: {32, 128, 256}, 
dropout: {0.0, 0.25, 0.5}, emb_dim: {100, 300, 500},  output_layer_size: {50, 100, 400}, 
lstm_layers: {1,2,4}, learning_rate: [1e-4, 1e-2]).  
For the final predicted pain events, all anatomical entities were normalized to UMLS concept 
unique identifiers (CUIs) using rule-based linking to the FMA. CUIs were linked to the most 
specific (i.e., longest distance to root node) concept in the FMA. 
Supplemental Results 
Structured revision record-free survival among implant systems  
Figure S2 summarizes the risk of revision for implant systems when including evidence from 
structured  records of revision only. Based on this data, no implant system is associated with a 
significantly higher or lower risk of revision. Figures S3-S7 summarize the risk of component 
wear, mechanical failure, particle disease, radiographic abnormality and infection (the 
complication subclasses detected by our extraction pipeline) for implant systems. 
 
  
 
 
Figure S2. Summary of Cox proportional hazards analysis of the risk of revision for each 
hip implant system, when including only structured records of revision. The table on the 
left lists the number of patients implanted with each system, the number of revision events 
observed for each based on structured records only, and the total person-years of data 
available. The forest plot displays the corresponding hazard ratio, with the hazard ratio (95% 
confidence interval) and p-value listed in the table to the right. Note that this figure only shows 
implant systems for which at least one revision event was detected. 
Post-implant complication-free survival among implant systems 
Figures S3-S7 summarize the risk of each class of post-implant complication for different 
implant systems, as derived by a Cox proportional hazards analysis. 
  
 
 
Figure S3. Summary of Cox proportional hazards analysis of the risk of component wear 
for each hip implant system. The table on the left lists the number of patients implanted with 
each system, the number of component wear events observed for each, and the total person-
years of data available. The forest plot displays the corresponding hazard ratio, with the hazard 
ratio (95% confidence interval) and p-value listed in the table to the right. Note that this figure 
only shows implant systems for which at least one component wear event was detected. 
 
  
 
 
Figure S4. Summary of Cox proportional hazards analysis of the risk of mechanical 
failure for each hip implant system. The table on the left lists the number of patients 
implanted with each system, the number of mechanical failure events observed for each, and 
the total person-years of data available. The forest plot displays the corresponding hazard ratio, 
with the hazard ratio (95% confidence interval) and p-value listed in the table to the right. Note 
that this figure only shows implant systems for which at least one mechanical failure event was 
detected. 
 
  
 
 
Figure S5. Summary of Cox proportional hazards analysis of the risk of particle disease 
for each hip implant system. The table on the left lists the number of patients implanted with 
each system, the number of particle disease events observed for each, and the total person-
years of data available. The forest plot displays the corresponding hazard ratio, with the hazard 
ratio (95% confidence interval) and p-value listed in the table to the right. Note that this figure 
only shows implant systems for which at least one particle disease event was detected. 
 
 
  
 
 
Figure S6. Summary of Cox proportional hazards analysis of the risk of radiographic 
abnormality for each hip implant system. The table on the left lists the number of patients 
implanted with each system, the number of radiographic abnormality events observed for each, 
and the total person-years of data available. The forest plot displays the corresponding hazard 
ratio, with the hazard ratio (95% confidence interval) and p-value listed in the table to the right. 
Note that this figure only shows implant systems for which at least one radiographic abnormality 
event was detected. 
 
  
 
 
Figure S7. Summary of Cox proportional hazards analysis of the risk of infection for each 
hip implant system. The table on the left lists the number of patients implanted with each 
system, the number of infection events observed for each, and the total person-years of data 
available. The forest plot displays the corresponding hazard ratio, with the hazard ratio (95% 
confidence interval) and p-value listed in the table to the right. Note that this figure only shows 
implant systems for which at least one infection event was detected. 
Post-implant hip pain is associated with implant system 
Table S1 lists the model coefficient estimate, incident rate ratio (IRR), lower and upper 95% 
confidence interval bounds, and p-values for the negative binomial model of hip pain in the year 
post-THA. 
  
 
Table S1. Negative binomial model coefficients, IRR (95% confidence interval) and p-value for 
hip pain in the year after THA. 
 Variable Estimate IRR (95% CI) p-value 
(Intercept) 0.828 2.290 (1.455-3.604) < 0.001 * 
Implant System 
Zimmer Biomet Trilogy + VerSys Reference 
Depuy Duraloc + AML -3.415 0.033 (0.012-0.091) < 0.001 * 
Depuy Duraloc + Corail 0.238 1.268 (1.020 -1.577) 0.033 * 
Depuy Duraloc + Summit -1.827 0.161 (0.040-0.652) 0.011 * 
Depuy M2A + Osteocap 0.408 1.504 (0.640-3.537) 0.350 
Depuy Pinnacle + AML -2.334 0.097 (0.057-0.164) < 0.001 * 
Depuy Pinnacle + Corail -0.521 0.594 (0.475-0.742) < 0.001 * 
Depuy Pinnacle + Endurance -3.431 0.032 (0.008-0.137) < 0.001 * 
Depuy Pinnacle + Solution -0.417 0.659 (0.199-2.187) 0.496 
Depuy Pinnacle + Summit -1.020 0.361 (0.301-0.432) < 0.001 * 
Depuy Pinnacle + TriLock -0.524 0.592 (0.300-1.171) 0.132 
Zimmer Biomet Continuum + Epoch 0.530 1.700 (0.679-4.257) 0.258 
Zimmer Biomet Continuum + M/L Taper 0.723 2.061 (1.561-2.720) < 0.001 * 
Zimmer Biomet Continuum + VerSys 0.589 1.802 (0.881-3.685) 0.107 
  
 
Zimmer Biomet Continuum + Wagner -0.352 0.703 (0.242-2.047) 0.518 
Zimmer Biomet Trilogy + Depuy AML -0.411 0.663 (0.321-1.367) 0.266 
Zimmer Biomet Trilogy + Epoch 0.313 1.368 (0.884-2.117) 0.160 
Zimmer Biomet Trilogy + M/L Taper 0.399 1.490 (1.234-1.799) < 0.001 * 
Zimmer Biomet Trilogy + Reach -0.345 0.708 (0.335-1.499) 0.367 
Zimmer Biomet Trilogy + Wagner 0.607 1.834 (1.120-3.004) 0.016 * 
Zimmer Biomet Trilogy + ZMR -0.237 0.789 (0.319-1.953) 0.608 
Other system -0.278 0.757 (0.504-1.138) 0.181 
Charlson Comorbidity Index 
None Reference 
Low 0.141 1.151 (0.956-1.386) 0.137 
Moderate 0.040 1.040 (0.809-1.338) 0.758 
High 0.234 1.264 (0.997-1.601) 0.053 
Age 
40-49 years Reference 
50-59 years -0.035 0.965 (0.794-1.174) 0.723 
60-69 years 0.050 1.051 (0.870-1.269) 0.606 
70-79 years -0.062 0.940 (0.768-1.151) 0.549 
80+ years -0.219 0.803 (0.632-1.020) 0.072 
  
 
Sex 
Female Reference 
Male 0.010 1.010 (0.898-1.137) 0.862 
Race 
Asian Reference 
Black 0.108 1.114 (0.726-1.709) 0.620 
Native American -0.171 0.843 (0.171-4.162) 0.834 
Other 0.394 1.482 (1.047-2.099) 0.027 * 
Pacific Islander 0.357 1.430 (0.598-3.420) 0.422 
Unknown 0.053 1.055 (0.684-1.626) 0.810 
White -0.030 0.970 (0.751-1.253) 0.817 
Ethnicity 
Hispanic Reference 
Not Hispanic 0.036 1.036 (0.746-1.439) 0.832 
Unknown -0.719 0.487 (0.328-0.723) < 0.001 * 
Other covariates 
Pain in year prior to THA 0.071 1.073 (1.049-1.099) < 0.001 * 
Follow-up time -0.001 0.999 (0.999-1.000) 0.001 * 
  
 
Relation extraction system performance 
Table S2 details Pain-Anatomy extraction performance given 150 - 50,000 weakly labeled 
training documents. Here we see performance improvements up to +9.2 F1 points over soft 
majority vote as we increase the scale of weakly labeled data provided to the deep learning 
model.  
Table S2. Pain-Anatomy Relation Extraction Performance 
 
Model 
Training Set Size (Number of Documents) 
150 5K 10K 50K 
P R F1 P R F1 P R F1 P R F1 
Supervised-LSTM ✦ 72.5 78.4 75.4 - - - - - - - - - 
Soft Majority Vote 81.4 64.8 72.2 - - - - - - - - - 
Weakly Supervised 
LSTM 
68.4 81.8 74.5 75.1 80.5 77.7 76.4 80.9 78.6 80.2 82.6 81.4 
✦ Uses hand-labeled training data 
Blue highlighting Highest achieved value for metric (P, R, F1) 
Table S3 contains a non-exhaustive list of example terms for each Implant-Complication 
category. These terms form disjoint sets for each Implant-Complication sub-category.  
 
 
 
 
 
 
  
 
Table S3. Example Terms for Implant-Complication Subcategories 
Subcategory Terms 
Mechanical failure hardware loosening, crooked, asymmetrically seated 
Revision reoperation, removals, revision, rebuilt, hardware removal 
Component wear polyethylene wear, worn, wearing, bearing surface wear, 
debonding 
Infection infection, septic, abscess, re-infected 
Particle disease particle disease, metal ion toxicity, metallosis 
Radiographic abnormality lucencies, pedestals, heterotopic calcifications, spurs 
 
